Can you provide the last earnings date for HARMONY BIOSCIENCES HOLDINGS?
HARMONY BIOSCIENCES HOLDINGS (HRMY) last reported earnings on 2/24/2026.
NASDAQ:HRMY • US4131971040
Past quarterly earnings results for HARMONY BIOSCIENCES HOLDINGS (HRMY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.38 | 0.91 | -58.44% | -55.29% | 243.776M | 245.19M | -0.58% | 21.12% |
| Q3 2025 | 0.87 | 0.86 | 1.62% | 10.13% | 239.455M | 228.15M | 4.96% | 28.71% |
| Q2 2025 | 0.68 | 0.77 | -11.17% | 240.00% | 200.489M | 207.68M | -3.46% | 16.01% |
| Q1 2025 | 0.78 | 0.60 | 31.00% | 16.42% | 184.733M | 186.56M | -0.98% | 19.48% |
| Q4 2024 | 0.85 | 0.75 | 12.80% | 88.89% | 201.267M | 205.01M | -1.83% | 19.51% |
| Q3 2024 | 0.79 | 0.68 | 16.47% | 5.33% | 186.038M | 187.74M | -0.91% | 16.08% |
| Q2 2024 | 0.20 | -0.06 | 409.61% | -64.29% | 172.814M | 175.98M | -1.80% | 28.76% |
| Q1 2024 | 0.67 | 0.62 | 8.70% | 1.52% | 154.615M | 157.18M | -1.63% | 29.79% |
| Q4 2023 | 0.45 | 0.49 | -7.85% | -43.04% | 168.412M | 172.44M | -2.34% | 31.26% |
| Q3 2023 | 0.75 | 0.66 | 13.12% | -47.92% | 160.268M | 151.58M | 5.73% | 36.75% |
| Q2 2023 | 0.56 | 0.65 | -13.20% | 43.59% | 134.216M | 144.87M | -7.35% | 25.44% |
| Q1 2023 | 0.66 | 0.48 | 37.31% | 29.41% | 119.126M | 118.52M | 0.51% | 39.66% |
| Q4 2022 | 0.79 | 0.59 | 33.82% | 107.89% | 128.3M | 129.89M | -1.22% | 40.68% |
| Q3 2022 | 1.44 | 0.14 | 951.28% | 947.06% | 117.2M | 115.81M | 1.20% | 45.23% |
| Q2 2022 | 0.39 | 0.45 | -13.10% | 62.50% | 107M | 102.77M | 4.12% | 44.99% |
| Q1 2022 | 0.51 | 0.30 | 69.90% | 34.21% | 85.3M | 90.324M | -5.56% | 42.88% |
| Q4 2021 | 0.38 | 0.36 | 4.45% | 52.00% | 91.2M | 91.316M | -0.13% | 61.99% |
| Q3 2021 | -0.17 | 0.30 | -157.47% | -21.43% | 80.7M | 81.58M | -1.08% | 76.97% |
| Q2 2021 | 0.24 | 0.18 | 33.18% | - | 73.8M | 70.278M | 5.01% | 94.21% |
| Q1 2021 | 0.38 | -0.03 | 1,496.88% | - | 59.7M | 58.208M | 2.56% | 201.52% |
| Q4 2020 | 0.25 | 0.09 | 172.33% | - | 56.3M | 52.891M | 6.45% | - |
| Q3 2020 | -0.14 | -0.05 | -174.51% | - | 45.6M | 40.868M | 11.58% | - |
| Q2 2020 | - | - | 38M | - | - | |||
| Q1 2020 | - | - | 19.8M | - | - |
Notes
HARMONY BIOSCIENCES HOLDINGS (HRMY) last reported earnings on 2/24/2026.
HARMONY BIOSCIENCES HOLDINGS (HRMY) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, HARMONY BIOSCIENCES HOLDINGS (HRMY) has beaten EPS estimates in 2 out of 4 releases.